Impax Laboratories, Inc. announced earlier this week that EMVERM (mebendazole) 100 mg chewable tablets are now available for healthcare providers to prescribe to patients in the United States. EMVERM...

Impax Laboratories, Inc. announced this week that the United States Food and Drug Administration (FDA) has approved the Company’s supplemental new drug application (sNDA) for EMVERM (mebendazole)...